ROSSARI452.00

Rossari Biotech Limited

· Chemicals
AnnualQuarterly₹ CrorePeersNOCILHSCLNAVINFLUORDDEVPLSTIKCHEMPLASTSTATACHEMAARTIINDJGCHEMMcap ₹2,503 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,830.62,080.32,396.43,093.6
Other Income7.44.022.425.6
Total Income1,838.02,084.32,418.73,119.1
Expenses
+ Cost of Materials Consumed1,229.91,299.61,603.72,118.4
+ Purchases of Stock-in-Trade127.1164.893.4108.1
+ Changes in Inventories-63.5-31.1-28.4-66.9
+ Employee Benefit Expense103.1132.3154.7198.8
+ Finance Costs19.417.828.539.5
+ Depreciation & Amortisation60.467.179.1104.7
+ Other Expenses184.1249.6287.0368.7
Total Expenses1,660.61,900.12,218.12,871.3
EBITDA249.8265.1285.9366.5
EBIT189.4198.0206.8261.8
Profit
PBT before Exceptional Items177.4184.2200.6247.8
Pretax Income177.4184.2200.6247.8
+ Current Tax55.859.161.377.4
+ Deferred Tax-8.9-10.3-8.0-11.5
Tax Expense46.948.853.365.9
+ Share of Associates & JVs0.21.01.92.4
Net Income130.7136.4149.2184.3
+ Net Income — Continuing Ops130.5135.4147.3182.0
+ Other Comprehensive Income0.0-1.00.10.4
Total Comprehensive Income130.7135.4149.3184.7
Net Income to Common130.7136.4149.2184.3
Per Share
Basic EPS23.6724.6626.9533.32
Diluted EPS23.6224.6326.9333.27
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.00.10.4
+ Items NOT to be Reclassified to P&L0.0-1.30.20.2
+ Tax on Items NOT to be Reclassified-0.30.00.1
+ Tax on Items NOT to be Reclassified — alt tag0.0
+ Items to be Reclassified to P&L-0.1
+ Tax on Items to be Reclassified0.1-0.0-0.1
Comprehensive Income — Owners of Parent130.7135.4149.3152.0
Per Share — as-filed variants
Basic EPS — Continuing Operations23.6724.6626.9533.32
Diluted EPS — Continuing Operations23.6224.6326.9333.27
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit537.0647.0727.6934.0
Gross Margin %29.3431.1030.3630.19
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)177.4184.2200.6247.8
Net Income Adj (tax-effected)130.7136.4149.2184.3
EPS Adj23.6724.6626.9533.32
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital11.011.111.111.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.